15 October 2026
MIT
SGLT2 Inhibitors: Why Their Benefit Isn't Measured in Blood Sugar, and What They Actually Protect
SGLT2 inhibitors are diabetes drugs whose biggest wins show up in the heart and kidneys, not the sugar number. What tria...